Open AccessTreatment of anaerobic phlegmon of the upper extremity induced by Clostridium perfringens via application of an oxygenated pharmaceutical
Author(s) -
A.M. Gololobov,
В В Мельников,
M.A. Topchiev,
Dmitry Parshin
Publication year - 2021
Publication title -
sibirskoe medicinskoe obozrenie
Language(s) - English
Resource type - Journals
eISSN - 2500-0136
pISSN - 1819-9496
DOI - 10.20333/25000136-2021-3-107-112
Subject(s) - clostridium perfringens , anaerobic exercise , phlegmon , medicine , population , incidence (geometry) , surgery , intensive care medicine , biology , physiology , bacteria , environmental health , genetics , physics , optics
At the present time, cases of gas infection are extremely rarely encountered. The incidence of anaerobic gas infection totals 0.1-1.0 cases in 1,000,000 of the population per year. The clinical case presented describes peculiarities in clinical progression of the disease, of its surgical and complex treatment. The dynamics of multiple organ dysfunction markers has been shown. On admission, the predicted lethal outcome rate totalled 66.7% to 82%. The treatment included local and peroral application of an oxygenated pharmaceutical. Tissue oximetry revealed elevation of blood oxygen saturation 30 and 60 minutes after the oxygenated pharmaceutical intake. The surgical tactics employed and the pathogenetic therapy combined with local and peroral application of the oxygenated pharmaceutical made it possible to achieve a positive treatment outcome